Related references
Note: Only part of the references are listed.Extension of the liquid chromatography/quantitative structure-property relationship method to assess the lipophilicity of neutral, acidic, basic and amphotheric drugs
Juan M. Pallicer et al.
JOURNAL OF CHROMATOGRAPHY A (2012)
Impact of Lipophilic Efficiency on Compound Quality
Akos Tarcsay et al.
JOURNAL OF MEDICINAL CHEMISTRY (2012)
The successful quest for oral factor Xa inhibitors; learnings for all of medicinal chemistry?
Robert J. Young
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2011)
Improving Drug Candidates by Design: A Focus on Physicochemical Properties As a Means of Improving Compound Disposition and Safety
Nicholas A. Meanwell
CHEMICAL RESEARCH IN TOXICOLOGY (2011)
Getting physical in drug discovery II: the impact of chromatographic hydrophobicity measurements and aromaticity
Robert J. Young et al.
DRUG DISCOVERY TODAY (2011)
Lipophilicity assessment of basic drugs (log Po/w determination) by a chromatographic method
Juan M. Pallicer et al.
JOURNAL OF CHROMATOGRAPHY A (2011)
What Do Medicinal Chemists Actually Make? A 50-Year Retrospective
W. Patrick Walters et al.
JOURNAL OF MEDICINAL CHEMISTRY (2011)
ADME Evaluation in Drug Discovery. 9. Prediction of Oral Bioavailability in Humans Based on Molecular Properties and Structural Fingerprints
Sheng Tian et al.
MOLECULAR PHARMACEUTICS (2011)
The influence of the 'organizational factor' on compound quality in drug discovery
Paul D. Leeson et al.
NATURE REVIEWS DRUG DISCOVERY (2011)
Probing the links between in vitro potency, ADMET and physicochemical parameters
M. Paul Gleeson et al.
NATURE REVIEWS DRUG DISCOVERY (2011)
Lipophilicity and Its Relationship with Passive Drug Permeation
Xiangli Liu et al.
PHARMACEUTICAL RESEARCH (2011)
Moving beyond Rules: The Development of a Central Nervous System Multiparameter Optimization (CNS MPO) Approach To Enable Alignment of Druglike Properties
Travis T. Wager et al.
ACS CHEMICAL NEUROSCIENCE (2010)
4-Methylpteridinones as orally active and selective PI3K/mTOR dual inhibitors
Kevin K-C. Liu et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2010)
Synthesis and SAR of novel imidazoles as potent and selective cannabinoid CB2 receptor antagonists with high binding efficiencies
Jos H. M. Lange et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2010)
Using an in vitro cytotoxicity assay to aid in compound selection for in vivo safety studies
Nigel Greene et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2010)
Phospholipidosis as a Function of Basicity, Lipophilicity, and Volume of Distribution of Compounds
Umesh M. Hanumegowda et al.
CHEMICAL RESEARCH IN TOXICOLOGY (2010)
Getting physical in drug discovery: a contemporary perspective on solubility and hydrophobicity
Alan P. Hill et al.
DRUG DISCOVERY TODAY (2010)
Lipophilicity in drug discovery
Michael J. Waring
EXPERT OPINION ON DRUG DISCOVERY (2010)
Physicochemical Space for Optimum Oral Bioavailability: Contribution of Human Intestinal Absorption and First-Pass Elimination
Manthena V. S. Varma et al.
JOURNAL OF MEDICINAL CHEMISTRY (2010)
Design of Selective, ATP-Competitive Inhibitors of Akt
Kevin D. Freeman-Cook et al.
JOURNAL OF MEDICINAL CHEMISTRY (2010)
Structure and function of the blood-brain barrier
N. Joan Abbott et al.
NEUROBIOLOGY OF DISEASE (2010)
Automated Potentiometric Titrations in KCl/Water-Saturated Octanol: Method for Quantifying Factors Influencing Ion-Pair Partitioning
Robert A. Scherrer et al.
ANALYTICAL CHEMISTRY (2009)
Pyrazole NNRTIs 4: Selection of UK-453,061 (lersivirine) as a Development Candidate
Charles E. Mowbray et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2009)
Rapid assessment of a novel series of selective CB2 agonists using parallel synthesis protocols: A Lipophilic Efficiency (LipE) analysis
Thomas Ryckmans et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2009)
Using the Golden Triangle to optimize clearance and oral absorption
Ted W. Johnson et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2009)
Defining optimum lipophilicity and molecular weight ranges for drug candidates-Molecular weight dependent lower logD limits based on permeability
Michael J. Waring
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2009)
Pharmacological Promiscuity: Dependence on Compound Properties and Target Specificity in a Set of Recent Roche Compounds
Jens-Uwe Peters et al.
CHEMMEDCHEM (2009)
Physicochemical drug properties associated with in vivo toxicological outcomes: a review
David A. Price et al.
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2009)
Physicochemical Determinants of Human Renal Clearance
Manthena V. S. Varma et al.
JOURNAL OF MEDICINAL CHEMISTRY (2009)
Calculation of Molecular Lipophilicity: State-of-the-Art and Comparison of Log P Methods on More Than 96,000 Compounds
Raimund Mannhold et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2009)
Structural Basis for the Design of PPAR-gamma Ligands: A Survey on Quantitative Structure-Activity Relationships
Costas Giaginis et al.
MINI-REVIEWS IN MEDICINAL CHEMISTRY (2009)
Biological characterization of AT7519, a small-molecule inhibitor of cyclin-dependent kinases, in human tumor cell lines
Matthew S. Squires et al.
MOLECULAR CANCER THERAPEUTICS (2009)
Soluble epoxide hydrolase as a therapeutic target for cardiovascular diseases
John D. Imig et al.
NATURE REVIEWS DRUG DISCOVERY (2009)
The influence of lead discovery strategies on the properties of drug candidates
Gyoergy M. Keserue et al.
NATURE REVIEWS DRUG DISCOVERY (2009)
Physiochemical drug properties associated with in vivo toxicological outcomes
Jason D. Hughes et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2008)
Cytochrome P450 and chemical toxicology
F. Peter Guengerich
CHEMICAL RESEARCH IN TOXICOLOGY (2008)
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds
R. Scott Obach et al.
DRUG METABOLISM AND DISPOSITION (2008)
Identification of N-(4-piperidinyl)-4-(2,6-dichlorobenzoylamino)-1H-pyrazole-3-carboxamide (AT7519), a novel cyclin dependent kinase inhibitor using fragment-based X-ray crystallography and structure based drug design
Paul G. Wyatt et al.
JOURNAL OF MEDICINAL CHEMISTRY (2008)
Generation of a set of simple, interpretable ADMET rules of thumb
M. Paul Gleeson
JOURNAL OF MEDICINAL CHEMISTRY (2008)
Drug-induced Phospholipidosis-Pathological Aspects and Its Prediction
Takashi Nonoyama et al.
JOURNAL OF TOXICOLOGIC PATHOLOGY (2008)
The influence of drug-like concepts on decision-making in medicinal chemistry
Paul D. Leeson et al.
NATURE REVIEWS DRUG DISCOVERY (2007)
Central nervous system drug disposition: The relationship between in situ brain permeability and brain free fraction
Scott G. Summerfield et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2007)
Analysis of pharmacology data and the prediction of adverse drug reactions and off-target effects from chemical structure
Andreas Bender et al.
CHEMMEDCHEM (2007)
Modeling promiscuity based on in vitro safety pharmacology profiling data
Kamal Azzaoui et al.
CHEMMEDCHEM (2007)
Identification of inhibitors of protein kinase B using fragment-based lead discovery
Gordon Saxty et al.
JOURNAL OF MEDICINAL CHEMISTRY (2007)
Evaluation of a published in silico model and construction of a novel bayesian model for predicting phospholipidosis inducing potential
Dennis J. Pelletier et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2007)
A quantitative assessment of hERG liability as a function of lipophilicity
Michael J. Waring et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2007)
Plasma protein binding affinity and its relationship to molecular structure: An in-silico analysis
M. Paul Gleeson
JOURNAL OF MEDICINAL CHEMISTRY (2007)
Structure-brain exposure relationships
Stephen A. Hitchcock et al.
JOURNAL OF MEDICINAL CHEMISTRY (2006)
In silico prediction of blood - Brain barrier permeation using the calculated molecular cross-sectional area as main parameter
Gregori Gerebtzoff et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2006)
Drug-induced phospholipidosis
Nora Anderson et al.
FEBS LETTERS (2006)
Medicinal chemistry of hERG optimizations: Highlights and hang-ups
Craig Jamieson et al.
JOURNAL OF MEDICINAL CHEMISTRY (2006)
The road map to oral bioavailability: an industrial perspective
V. Hayden Thomas et al.
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2006)
Drug-induced phospholipidosis: issues and future directions
Mark J. Reasor et al.
EXPERT OPINION ON DRUG SAFETY (2006)
Structural basis of the drug-binding specificity of human serum albumin
J Ghuman et al.
JOURNAL OF MOLECULAR BIOLOGY (2005)
A bioavailability score
YC Martin
JOURNAL OF MEDICINAL CHEMISTRY (2005)
Prediction of human volume of distribution values for neutral and basic drugs. 2. Extended data set and leave-class-out statistics
F Lombardo et al.
JOURNAL OF MEDICINAL CHEMISTRY (2004)
Improving the decision-making process in structural modification of drug candidates: reducing toxicity
AEF Nassar et al.
DRUG DISCOVERY TODAY (2004)
Time-related differences in the physical property profiles of oral drugs
PD Leeson et al.
JOURNAL OF MEDICINAL CHEMISTRY (2004)
Relationships between preclinical cardiac electrophysiology, clinical QT interval prolongation and torsade de pointes for a broad range of drugs: evidence for a provisional safety margin in drug development
WS Redfern et al.
CARDIOVASCULAR RESEARCH (2003)
A comparison of physiochemical property profiles of development and marketed oral drugs
MC Wenlock et al.
JOURNAL OF MEDICINAL CHEMISTRY (2003)
The price of innovation: new estimates of drug development costs
JA DiMasi et al.
JOURNAL OF HEALTH ECONOMICS (2003)
Fast gradient HPLC method to determine compounds binding to human serum albumin. Relationships with octanol/water and immobilized artificial membrane lipophilicity
K Valko et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2003)
Baseline lipophilicity relationships in human cytochromes P450 associated with drug metabolism
DFV Lewis et al.
DRUG METABOLISM REVIEWS (2003)
Substrate SARs in human P450s
DFV Lewis et al.
DRUG DISCOVERY TODAY (2002)
Toward a pharmacophore for drugs inducing the long QT syndrome:: Insights from a CoMFA study of HERG K+ channel blockers
A Cavalli et al.
JOURNAL OF MEDICINAL CHEMISTRY (2002)
Prediction of volume of distribution values in humans for neutral and basic drugs using physicochemical measurements and plasma protein binding data
F Lombardo et al.
JOURNAL OF MEDICINAL CHEMISTRY (2002)
Molecular properties that influence the oral bioavailability of drug candidates
DF Veber et al.
JOURNAL OF MEDICINAL CHEMISTRY (2002)
Prediction of aqueous solubility of organic compounds by the general solubility equation (GSE)
YQ Ran et al.
JOURNAL OF CHEMICAL INFORMATION AND COMPUTER SCIENCES (2001)
Property-based design: Optimization of drug absorption and pharmacokinetics
H van de Waterbeemd et al.
JOURNAL OF MEDICINAL CHEMISTRY (2001)
Lipophilicity in PK design: methyl, ethyl, futile
H van de Waterbeemd et al.
JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN (2001)
Physicochemical properties in pharmacokinetic lead optimization
SD Kramer et al.
FARMACO (2001)
An increased throughput method for the determination of partition coefficients
L Hitzel et al.
PHARMACEUTICAL RESEARCH (2000)
Prediction of drug absorption using multivariate statistics
WJ Egan et al.
JOURNAL OF MEDICINAL CHEMISTRY (2000)
QSAR model for drug human oral bioavailability
F Yoshida et al.
JOURNAL OF MEDICINAL CHEMISTRY (2000)
Share Paper
